NEI Research News

The National Eye Institute has published "Stem cell sources and characterization in the development of cell-based products for treating retinal disease: An NEI town hall report."

A new study on herpes infections of the eye from University of Illinois Chicago researchers identifies a key protein involved in viral reinfections that could be targeted by antiviral drugs.

Study from University of Washington shows some nerve cell circuits for color vision are uniquely human.

A successful gene therapy trialed at Michigan State University in dogs with an inherited eye disease is ready to be developed for clinical use in human patients with a rare condition called retinitis pigmentosa.

Augusta University scientists have found a new target and drug that together appear to stop retinopathy of prematurity.

Syndrome is a leading cause of combined deafness-blindness

Researchers at the State University of New York help explain how reading might contribute to myopia.

A study from the National Eye Institute (NEI) identified rare genetic variants that could point to one of the general mechanisms driving age-related macular degeneration (AMD), a common cause of vision loss in older adults.

Texas Congressman Pete Sessions visited the NIH March 27 to meet with NEI Director Michael F. Chiang, M.D., and to tour NEI’s Section on Ocular and Stem Cell Translational Research, led by Kapil Bharti, Ph.D.

A National Eye Institute-led team has identified a compound already approved by the U.S. Food and Drug Administration that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10 (LCA 10).